AI-Driven Early Warning System for Perioperative Risks in Acute Hemorrhagic Stroke

Launched by BEIJING TIANTAN HOSPITAL · May 28, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a new system that uses artificial intelligence (AI) to help predict and manage risks during surgery for patients with acute hemorrhagic stroke, a serious condition caused by bleeding in the brain. The goal is to create a tool that monitors patients in real-time and helps doctors make better decisions to reduce complications after surgery. By analyzing various health data, the AI system aims to identify potential problems before they occur, ultimately improving patient outcomes and lowering the chances of severe complications.

To participate in this trial, individuals need to be between 18 and 80 years old and have a confirmed diagnosis of specific conditions related to brain bleeding, such as an intracranial aneurysm or spontaneous intracerebral hemorrhage. They must also be scheduled for surgery within a week of their symptoms starting. Participants can expect to have their health closely monitored during the study, which may help improve surgical care for future patients with similar conditions. It's important to note that patients who choose not to participate or are involved in other conflicting studies will not be eligible for this trial.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients aged 18 to 80 years.
• * Diagnosis confirmed by preoperative imaging (CT or MRI) of one of the following conditions:
• • Intracranial aneurysm
• • Arteriovenous malformation (AVM)
• • Hemorrhagic moyamoya disease
• • Cavernous malformation
• • Spontaneous intracerebral hemorrhage
• • Undergoing surgery within seven days of symptom onset.
• Exclusion Criteria:
• • Patients who decline to provide informed consent.
• • Patients enrolled in conflicting clinical studies.